Articles

YUUZOO CORPORATION

Otonomy Announces FDA Approval of OTIPRIO(R) for Acute Otitis Externa

NORT AMERICAN CANNABIS

CAC40

$ ZOSANO..... vive hausse pour cause

Biogen and AbbVie Announce the Voluntary Worldwide Withdrawal of Marketing Authorizations for ZINBRYTA® (daclizumab) for Relapsing Multiple Sclerosis | Business Wire

FDA

Reata Announces Top-Line Data from the Dose-Escalation Cohorts of the Phase 2 Motor Study of Omaveloxolone in Patients With Mitochondrial Myopathies

$ PAIN THERAPEUTICS

TARKETT

Recommandations